The MYC gene has a confirmed role in the pathogenesis of MM by intensifying cell proliferation and migration (Notch and Wnt signaling pathways) and stimulating angiogenesis (via VEGF), and its increased activity is associated with tumor progression and occurs in up to 60% of disease cases [55]. The gene discussed is VEGFA; the disease is Miyoshi myopathy.